Largest pharmaceuticals by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 pharmaceuticals ranked by earnings, at CZK 595.6B, ahead of Eli Lilly (CZK 458.6B) and Merck & Co (CZK 405.6B). Figures as of 18 Nov 2026, 15:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonCZK 595.6B
- Median
- CZK 1.3B
- Combined market value
- CZK 113.95T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | CZK 595.6B | CZK 14.82T | CZK 6,157.63 | 0.56% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | CZK 458.6B | CZK 27.74T | CZK 31,144.68 | 0.98% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | CZK 405.6B | CZK 7.75T | CZK 3,144.48 | 1.29% down | 51% up | ||
| 4 | Novo NordiskNVO · Health Care | CZK 337.8B | CZK 3.94T | CZK 892.99 | 1.25% down | 17% down | ||
| 5 | NovartisNVS · Health Care | CZK 310.7B | CZK 6.6T | CZK 3,495.10 | 1.15% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | CZK 227.2B | CZK 6.22T | CZK 4,008.58 | 1.02% down | 2% up | ||
| 7 | SanofiSNY · Health Care | CZK 192.6B | CZK 2.54T | CZK 1,056.75 | 0.06% up | 4% down | ||
| 8 | PfizerPFE · Health Care | CZK 172.7B | CZK 3.58T | CZK 628.92 | 0.58% down | 14% up | ||
| 9 | GSKGSK · Health Care | CZK 168.6B | CZK 2.19T | CZK 1,092.08 | 0.18% down | 6% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | CZK 156.7B | CZK 2.76T | CZK 1,347.93 | 1.12% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | CZK 145B | CZK 4.04T | CZK 2,330.14 | 0.15% up | 17% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | CZK 100.1B | CZK 2.21T | CZK 21,370.08 | 0.42% up | 36% up | ||
| 13 | AbbVieABBV · Health Care | CZK 93.9B | CZK 11.43T | CZK 6,465.26 | 0.63% down | 26% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | CZK 87.8B | CZK 3.05T | CZK 12,027.25 | 1.33% up | 27% up | ||
| 15 | ZoetisZTS · Health Care | CZK 59.4B | CZK 756B | CZK 1,860.64 | 0.31% up | 29% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | CZK 31.3B | CZK 1.11T | CZK 952.54 | 0.59% up | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | CZK 29.7B | CZK 549.2B | CZK 12,895.97 | 0.63% down | 23% up | ||
| 18 | GenmabGMAB · Health Care | CZK 21.4B | CZK 708.3B | CZK 1,148.74 | 0.50% down | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | CZK 17.1B | CZK 880B | CZK 1,530.47 | 0.29% up | 78% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | CZK 15.2B | CZK 112.5B | CZK 1,346.93 | 0.43% up | 20% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | CZK 10.1B | CZK 277.4B | CZK 332.73 | 1.18% up | 5% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | CZK 9.9B | CZK 214.7B | CZK 1,420.70 | 1.96% up | 107% up | ||
| 23 | GrifolsGRFS · Health Care | CZK 9.9B | CZK 130B | CZK 191.09 | 0.35% down | 1% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | CZK 7.8B | CZK 255.3B | CZK 1,317.82 | 1.37% up | 11% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | CZK 7B | CZK 464.3B | CZK 3,466.54 | 0.31% down | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | CZK 6.4B | CZK 1.03T | CZK 9,029.37 | 1.67% down | 17% up | ||
| 27 | AlkermesALKS · Health Care | CZK 5.4B | CZK 173.1B | CZK 1,029.98 | 1.99% up | 58% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | CZK 2.8B | CZK 131.7B | CZK 6,585.36 | 0.87% up | 43% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | CZK 2.2B | CZK 170.4B | CZK 1,557.24 | 0.02% up | 8% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | CZK 1.6B | CZK 166.6B | CZK 478.16 | 1.89% up | 83% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CZK 1.3B | CZK 168.7B | CZK 2,146.61 | 1.58% up | 126% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -CZK 36.2M | CZK 137.3B | CZK 970.98 | 1.65% up | 10% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -CZK 519.1M | CZK 133.5B | CZK 2,044.51 | 0.07% up | 31% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -CZK 567.6M | CZK 108.3B | CZK 1,128.13 | 0.64% down | 44% up | ||
| 35 | VeradermicsMANE · Health Care | -CZK 1.6B | CZK 118.9B | CZK 2,817.85 | 0.94% up | 233% up | ||
| 36 | Belite BioBLTE · Health Care | -CZK 1.7B | CZK 142.5B | CZK 3,509.33 | 0.14% up | 31% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -CZK 2.3B | CZK 147.7B | CZK 2,177.71 | 1.75% up | 241% up | ||
| 38 | ErascaERAS · Health Care | -CZK 2.8B | CZK 105.6B | CZK 300.96 | 2.48% down | 403% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -CZK 2.9B | CZK 182.7B | CZK 2,799.08 | 1.05% up | 46% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -CZK 3.4B | CZK 202.5B | CZK 2,132.61 | 2.31% up | 286% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -CZK 3.6B | CZK 110.1B | CZK 1,954.63 | 1.14% up | 113% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -CZK 3.7B | CZK 101.1B | CZK 923.77 | 1.11% down | 88% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -CZK 4.1B | CZK 157.8B | CZK 2,999.61 | 0.70% down | 7% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -CZK 4.1B | CZK 89.9B | CZK 656.47 | 0.56% up | 169% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -CZK 4.4B | CZK 179.2B | CZK 2,584.88 | 0.24% down | 13% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -CZK 5.2B | CZK 292.3B | CZK 584.81 | 1.82% up | 20% up | ||
| 47 | Ascendis PharmaASND · Health Care | -CZK 5.6B | CZK 395.3B | CZK 6,026.99 | 0.02% up | 28% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -CZK 6.4B | CZK 217B | CZK 9,340.99 | 0.38% down | 24% down | ||
| 49 | Legend BiotechLEGN · Health Care | -CZK 6.6B | CZK 70.8B | CZK 365.06 | 1.99% up | 42% down | ||
| 50 | Roivant SciencesROIV · Health Care | -CZK 6.7B | CZK 630.1B | CZK 869.66 | 1.11% up | 90% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -CZK 6.7B | CZK 193.1B | CZK 6,908.20 | 1.92% up | 61% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -CZK 7.3B | CZK 109.6B | CZK 629.92 | 1.80% up | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -CZK 7.9B | CZK 346.3B | CZK 5,395.62 | 0.88% up | 37% up | ||
| 54 | ABIVAXABVX · Health Care | -CZK 8.3B | CZK 163.3B | CZK 1,865.64 | 2.27% up | 27% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -CZK 8.5B | CZK 101.4B | CZK 608.59 | 1.59% up | 64% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -CZK 16.3B | CZK 336.6B | CZK 1,727.77 | 1.25% up | 17% up | ||
| 57 | CytokineticsCYTK · Health Care | -CZK 17.4B | CZK 162.7B | CZK 1,168.07 | 1.78% up | 20% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -CZK 21.2B | CZK 1.53T | CZK 477.94 | 0.60% down | 54% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -CZK 24B | CZK 200.8B | CZK 251.14 | 5.93% up | 36% down | ||
| 60 | InsmedINSM · Health Care | -CZK 28.4B | CZK 594.3B | CZK 2,709.20 | 0.06% up | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -CZK 78.1B | CZK 527.2B | CZK 459.83 | 1.20% up | 96% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2193 CZK).
Questions and answers
Which pharmaceuticals rank first by earnings?
Johnson & Johnson (CZK 595.6B), Eli Lilly (CZK 458.6B) and Merck & Co (CZK 405.6B) are the top three of the 61 pharmaceuticals ranked by earnings as of 18 Nov 2026, 15:06 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by earnings.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by earnings have a combined market value of CZK 113.95T as of 18 Nov 2026, 15:06 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceuticals by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.